← FDA Drug Approvals (Drugs@FDA)
ZUMANDIMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-03-26
Drug application
- FDA Application #
ANDA209407
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ZUMANDIMINE
- Generic name
- DROSPIRENONE AND ETHINYL ESTRADIOL
- Active ingredients
- DROSPIRENONE; ETHINYL ESTRADIOL
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2018-03-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown